Increased soluble urokinase plasminogen activator levels modulate monocyte function to promote atherosclerosis-Reference-Cited by-同舟云学术

Increased soluble urokinase plasminogen activator levels modulate monocyte function to promote atherosclerosis

Published:2022-12-15 Issue:24 Volume:132 Page:
ISSN:1558-8238
Container-title:Journal of Clinical Investigation
language:en
Short-container-title:

Author:

Hindy George^ORCID,Tyrrell Daniel J.^ORCID,Vasbinder Alexi^ORCID,Wei Changli,Presswalla Feriel^ORCID,Wang Hui,Blakely Pennelope,Ozel Ayse Bilge,Graham Sarah,Holton Grace H.,Dowsett Joseph^ORCID,Fahed Akl C.,Amadi Kingsley-Michael,Erne Grace K.,Tekmulla Annika,Ismail Anis^ORCID,Launius Christopher,Sotoodehnia Nona,Pankow James S.^ORCID,Thørner Lise Wegner,Erikstrup Christian^ORCID,Pedersen Ole Birger^ORCID,Banasik Karina^ORCID,Brunak Søren^ORCID,Ullum Henrik,Eugen-Olsen Jesper,Ostrowski Sisse Rye^ORCID,Haas Mary E.^ORCID,Nielsen Jonas B.^ORCID,Lotta Luca A.,Engström Gunnar,Melander Olle,Orho-Melander Marju^ORCID,Zhao Lili,Murthy Venkatesh L.^ORCID,Pinsky David J.,Willer Cristen J.,Heckbert Susan R.^ORCID,Reiser Jochen,Goldstein Daniel R.^ORCID,Desch Karl C.,Hayek Salim S.^ORCID

Funder

NHLBI

NIDDK

Gilead Foundation

Michigan Institute for Clinical & Health Research

Publisher

American Society for Clinical Investigation

Subject

General Medicine

Link

https://www.jci.org/articles/view/158788/files/pdf

Reference99 articles.